Effective long-term androgen suppression in men with prostate cancer using a hydrogel implant with the GnRH agonist histrelin

Author： Schlegel P.N.   Kuzma P.   Frick J.   Farkas A.   Gomahr A.   Spitz I.   Chertin B.   Mack D.   Jungwirth A.   King P.   Nash H.   Bardin C.W.   Moo-Young A.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.58, Iss.4, 2001-10, pp. : 578-582

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term survival in a swedish population-based cohort of men with prostate cancer

By Sandblom G.   Dufmats M.   Varenhorst E.  

Urology, Vol. 56, Iss. 3, 2000-09 ,pp. : 442-447

Elsevier

Access to resources Recommend Favorite

Individual variation of hormonal recovery after cessation of luteinizing hormone-releasing hormone agonist therapy in men receiving long-term medical castration therapy for prostate cancer

By Kobayashi Takashi   Nishizawa Koji   Mitsumori Kenji  

Scandinavian Journal of Urology and Nephrology, Vol. 40, Iss. 3, 2006-05 ,pp. : 198-203

Informa Healthcare

Access to resources Recommend Favorite

Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer?

By Labrie F.   Candas B.   Gomez J.-L.   Cusan L.  

Urology, Vol. 60, Iss. 1, 2002-07 ,pp. : 115-119

Elsevier

Access to resources Recommend Favorite

Effect of endocrine treatment on voiding and prostate size in men with prostate cancer: A long-term prospective study

By Klarskov Louise L.  

Scandinavian Journal of Urology and Nephrology, Vol. 46, Iss. 1, 2012-02 ,pp. : 37-43

Informa Healthcare

Access to resources Recommend Favorite

Giant multilocular cystadenoma of the prostate responsive to GnRH antagonists

By Datta M.W.   Hosenpud J.   Osipov V.   Young R.H.  

Urology, Vol. 61, Iss. 1, 2003-01 ,pp. : 225-225

Elsevier

Access to resources Recommend Favorite